| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.595.006 | 5.591.365 | 6.110.500 | 6.184.746 | 6.314.406 | 7.137.741 | 10.657.760 | 12.091.959 | 10.016.722 | 14.420.028 |
| Total Income - EUR | 4.719.975 | 5.509.380 | 6.191.819 | 6.568.600 | 6.413.207 | 7.242.763 | 10.829.247 | 12.010.332 | 9.720.045 | 14.564.632 |
| Total Expenses - EUR | 3.266.979 | 3.491.101 | 4.756.611 | 4.376.923 | 4.122.708 | 4.403.516 | 4.719.048 | 5.139.135 | 5.739.568 | 5.909.029 |
| Gross Profit/Loss - EUR | 1.452.996 | 2.018.279 | 1.435.208 | 2.191.677 | 2.290.499 | 2.839.247 | 6.110.198 | 6.871.198 | 3.980.477 | 8.655.603 |
| Net Profit/Loss - EUR | 1.224.277 | 1.690.947 | 1.205.529 | 1.861.956 | 1.915.301 | 2.409.755 | 5.203.334 | 5.831.788 | 3.537.883 | 7.435.076 |
| Employees | 43 | 43 | 72 | 52 | 48 | 49 | 44 | 50 | 0 | 54 |
Check the financial reports for the company - Parapharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.708.126 | 2.331.268 | 2.494.788 | 2.467.000 | 2.067.534 | 2.184.135 | 1.773.838 | 1.498.944 | 1.660.342 | 1.585.007 |
| Current Assets | 6.921.702 | 5.814.857 | 5.881.765 | 5.956.280 | 5.108.183 | 5.167.901 | 7.842.657 | 16.202.904 | 9.999.600 | 17.800.423 |
| Inventories | 3.970.831 | 4.567.064 | 4.007.720 | 3.421.672 | 3.597.376 | 3.451.661 | 3.734.829 | 4.611.979 | 4.589.578 | 4.818.845 |
| Receivables | 1.625.769 | 1.194.074 | 1.417.930 | 2.439.089 | 1.410.851 | 1.393.731 | 3.982.935 | 11.376.375 | 5.313.237 | 12.943.437 |
| Cash | 1.325.103 | 53.719 | 456.115 | 95.518 | 99.955 | 322.509 | 124.893 | 0 | 96.786 | 38.141 |
| Shareholders Funds | 4.191.636 | 3.712.097 | 4.854.819 | 2.974.516 | 2.491.921 | 2.975.444 | 5.756.478 | 6.386.648 | 4.998.214 | 8.637.478 |
| Social Capital | 26.533 | 137.601 | 135.273 | 132.790 | 130.219 | 127.750 | 124.917 | 125.305 | 124.925 | 124.227 |
| Debts | 4.458.020 | 4.480.708 | 3.541.171 | 5.452.687 | 4.695.001 | 4.376.592 | 3.860.264 | 11.325.975 | 6.664.463 | 10.144.851 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 603.102 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1089 - 1089" | |||||||||
| CAEN Financial Year |
1089
|
|||||||||
Comments - Parapharm Srl